Wellness Wire Kansas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Wire Kansas.

Press releases published on June 15, 2026

10 hours ago

Vaxart to Showcase Oral Vaccine Platform and Strategic Vision at BIO 2026 and Taiwan Biotech Forum

Indeterminate GlobeNewswire

10 hours ago

Reunion Neuroscience Announces Appointment of Sahil V. Kirpekar, M.D., as President and CEO

Indeterminate GlobeNewswire

10 hours ago

Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2026 EHA Congress in Oral Presentation

Indeterminate GlobeNewswire

10 hours ago

Immuneering Appoints Andrew Gengos as Chief Financial Officer

Indeterminate GlobeNewswire

10 hours ago

Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome

Indeterminate GlobeNewswire

10 hours ago

10 Barrel Brewing and Pub Beer Kick Off Pacific Northwest Summer of Soccer Celebration

Indeterminate GlobeNewswire

10 hours ago

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

Indeterminate GlobeNewswire

11 hours ago

Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company

Indeterminate GlobeNewswire

11 hours ago

Kraig Biocraft Laboratories CEO Kim Thompson Highlights Commercial Scale, Competitive Advantages, and the Future of Spider Silk in Featured Pulse 2.0 Interview

Indeterminate GlobeNewswire

11 hours ago

Pasithea Therapeutics Announces Exhibit at Children’s Tumor Foundation 2026 NF Conference

Indeterminate GlobeNewswire

11 hours ago

HMNC Brain Health announces $50 million first closing of Series B financing and a strategic partnership with MEDICE

Indeterminate GlobeNewswire

11 hours ago

4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board

Indeterminate GlobeNewswire

11 hours ago

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign

Indeterminate GlobeNewswire

11 hours ago

Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer

Indeterminate GlobeNewswire

11 hours ago

Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026

Indeterminate GlobeNewswire

11 hours ago

Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia

Indeterminate GlobeNewswire

11 hours ago

Shock Top Kicks Off the World’s Biggest Summer of Soccer with Shocking Upsets

Indeterminate GlobeNewswire

11 hours ago

XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO

Indeterminate GlobeNewswire

11 hours ago

Vireo Growth Inc. and C21 Investments Inc. Announce Definitive Arrangement Agreement

Indeterminate GlobeNewswire

11 hours ago

Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman

Indeterminate GlobeNewswire